These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15176427)

  • 1. Molecular determinants of altered contractility in heart failure.
    Wehrens XH; Marks AR
    Ann Med; 2004; 36 Suppl 1():70-80. PubMed ID: 15176427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
    Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
    Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered function and regulation of cardiac ryanodine receptors in cardiac disease.
    Wehrens XH; Marks AR
    Trends Biochem Sci; 2003 Dec; 28(12):671-8. PubMed ID: 14659699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.
    Reiken S; Wehrens XH; Vest JA; Barbone A; Klotz S; Mancini D; Burkhoff D; Marks AR
    Circulation; 2003 May; 107(19):2459-66. PubMed ID: 12743001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac ryanodine receptor function and regulation in heart disease.
    Lehnart SE; Wehrens XH; Kushnir A; Marks AR
    Ann N Y Acad Sci; 2004 May; 1015():144-59. PubMed ID: 15201156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure.
    Reiken S; Gaburjakova M; Gaburjakova J; He Kl KL; Prieto A; Becker E; Yi Gh GH; Wang J; Burkhoff D; Marks AR
    Circulation; 2001 Dec; 104(23):2843-8. PubMed ID: 11733405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca(2+)-handling proteins and heart failure: novel molecular targets?
    Prestle J; Quinn FR; Smith GL
    Curr Med Chem; 2003 Jun; 10(11):967-81. PubMed ID: 12678683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of carvedilol on ryanodine receptor in heart failure].
    Li R; Yi QJ; Qian YR; Liu XY
    Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):603-7. PubMed ID: 16191273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure.
    Jiang MT; Lokuta AJ; Farrell EF; Wolff MR; Haworth RA; Valdivia HH
    Circ Res; 2002 Nov; 91(11):1015-22. PubMed ID: 12456487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal ryanodine receptor function in heart failure.
    Yano M; Yamamoto T; Ikemoto N; Matsuzaki M
    Pharmacol Ther; 2005 Sep; 107(3):377-91. PubMed ID: 15951021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death.
    Marks AR
    J Mol Cell Cardiol; 2001 Apr; 33(4):615-24. PubMed ID: 11273716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ryanodine receptors, FKBP12, and heart failure.
    Marks AR
    Front Biosci; 2002 Apr; 7():d970-7. PubMed ID: 11897558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation.
    El-Armouche A; Boknik P; Eschenhagen T; Carrier L; Knaut M; Ravens U; Dobrev D
    Circulation; 2006 Aug; 114(7):670-80. PubMed ID: 16894034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon beta-adrenergic stimulation in normal and failing hearts.
    Xiao B; Zhong G; Obayashi M; Yang D; Chen K; Walsh MP; Shimoni Y; Cheng H; Ter Keurs H; Chen SR
    Biochem J; 2006 May; 396(1):7-16. PubMed ID: 16483256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calstabin deficiency, ryanodine receptors, and sudden cardiac death.
    Lehnart SE; Wehrens XH; Marks AR
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1267-79. PubMed ID: 15336974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor.
    Benkusky NA; Weber CS; Scherman JA; Farrell EF; Hacker TA; John MC; Powers PA; Valdivia HH
    Circ Res; 2007 Oct; 101(8):819-29. PubMed ID: 17717301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.
    Marx SO; Reiken S; Hisamatsu Y; Jayaraman T; Burkhoff D; Rosemblit N; Marks AR
    Cell; 2000 May; 101(4):365-76. PubMed ID: 10830164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression.
    Wehrens XH; Lehnart SE; Reiken S; Vest JA; Wronska A; Marks AR
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):511-8. PubMed ID: 16407108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure.
    Okuda S; Yano M; Doi M; Oda T; Tokuhisa T; Kohno M; Kobayashi S; Yamamoto T; Ohkusa T; Matsuzaki M
    Circulation; 2004 Feb; 109(7):911-9. PubMed ID: 14757694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium dynamics in the failing heart: restoration by beta-adrenergic receptor blockade.
    Plank DM; Yatani A; Ritsu H; Witt S; Glascock B; Lalli MJ; Periasamy M; Fiset C; Benkusky N; Valdivia HH; Sussman MA
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H305-15. PubMed ID: 12649072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.